Selon les derniers rapports financiers d'Abbott Laboratories, l'entreprise a un ratio cours/valeur comptable de 5.2597.
Le ratio cours/valeur comptable est une façon de mesurer combien le marché boursier pense qu'une entreprise vaut par rapport à la valeur de ses actifs sur papier.
Année | Ratio cours/valeur comptable | Changement |
---|---|---|
2025-12-31 | N/A | -100% |
2024-12-31 | 4.16 | -15.4% |
2023-12-31 | 4.92 | -5.12% |
2022-12-31 | 5.19 | -24.92% |
2021-12-31 | 6.91 | 17.49% |
2020-12-31 | 5.88 | 20.22% |
2019-12-31 | 4.89 | 18.33% |
2018-12-31 | 4.13 | 29.4% |
2017-12-31 | 3.19 | 17.02% |
2016-12-31 | 2.73 | -11.98% |
2015-12-31 | 3.10 | -1.15% |
2014-12-31 | 3.14 | 33.6% |
2013-12-31 | 2.35 | -39.03% |
2012-12-31 | 3.85 | 7.84% |
2011-12-31 | 3.57 | 9.7% |
2010-12-31 | 3.26 | -10.98% |
2009-12-31 | 3.66 | -22.63% |
2008-12-31 | 4.73 | -3.44% |
2007-12-31 | 4.90 | -8.12% |
2006-12-31 | 5.33 | 26.55% |
2005-12-31 | 4.21 | -17.12% |
2004-12-31 | 5.08 | -9.34% |
2003-12-31 | 5.60 | -4.87% |
2002-12-31 | 5.89 |
Entreprise | Ratio cours/valeur comptable | Ratio cours/valeur comptable différencediff. | Pays |
---|---|---|---|
![]() Johnson & Johnson JNJ | 5.18 | 14.19% | 🇺🇸 USA |
![]() Pfizer PFE | 1.52 | -66.42% | 🇺🇸 USA |
![]() Thermo Fisher Scientific TMO | 3.68 | -18.97% | 🇺🇸 USA |
![]() Hologic HOLX | 3.19 | -29.81% | 🇺🇸 USA |
![]() Medtronic MDT | 2.45 | -45.93% | 🇮🇪 Ireland |
![]() Bristol-Myers Squibb BMY | 5.47 | 20.41% | 🇺🇸 USA |
![]() Boston Scientific BSX | 7.02 | 54.60% | 🇺🇸 USA |
![]() AstraZeneca AZN | 5.66 | 24.78% | 🇬🇧 UK |
![]() Novartis NVS | 5.96 | 31.30% | 🇨🇭 Switzerland |
![]() GlaxoSmithKline GSK | 4.33 | -4.62% | 🇬🇧 UK |